0.945 USD
-0.06 (-5.5%)
Last: Feb 2, 2026, 04:30 PM
Overall TELA gets a fundamental rating of 2 out of 10. We evaluated TELA against 186 industry peers in the Health Care Equipment & Supplies industry. TELA may be in some trouble as it scores bad on both profitability and health. TELA is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year TELA has reported negative net income.
- In the past year TELA has reported a negative cash flow from operations.
- TELA had negative earnings in each of the past 5 years.
- TELA had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- TELA's Return On Assets of -63.32% is on the low side compared to the rest of the industry. TELA is outperformed by 69.89% of its industry peers.
- The Return On Equity of TELA (-2504.69%) is worse than 86.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -63.32% | ||
| ROE | -2504.69% | ||
| ROIC | N/A |
ROA(3y)-56.26%
ROA(5y)-51.06%
ROE(3y)-229.9%
ROE(5y)-182.8%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- TELA's Gross Margin of 67.23% is fine compared to the rest of the industry. TELA outperforms 72.58% of its industry peers.
- In the last couple of years the Gross Margin of TELA has grown nicely.
- TELA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 67.23% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.66%
GM growth 5Y2.26%
2. Health
2.1 Basic Checks
- TELA does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for TELA has been increased compared to 1 year ago.
- The number of shares outstanding for TELA has been increased compared to 5 years ago.
- TELA has a better debt/assets ratio than last year.
2.2 Solvency
- TELA has an Altman-Z score of -8.28. This is a bad value and indicates that TELA is not financially healthy and even has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of -8.28, TELA is doing worse than 74.19% of the companies in the same industry.
- A Debt/Equity ratio of 26.65 is on the high side and indicates that TELA has dependencies on debt financing.
- TELA has a worse Debt to Equity ratio (26.65) than 87.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 26.65 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -8.28 |
ROIC/WACCN/A
WACC11.3%
2.3 Liquidity
- A Current Ratio of 3.30 indicates that TELA has no problem at all paying its short term obligations.
- The Current ratio of TELA (3.30) is better than 60.22% of its industry peers.
- TELA has a Quick Ratio of 2.62. This indicates that TELA is financially healthy and has no problem in meeting its short term obligations.
- TELA's Quick ratio of 2.62 is fine compared to the rest of the industry. TELA outperforms 61.83% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.3 | ||
| Quick Ratio | 2.62 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 47.34% over the past year.
- Looking at the last year, TELA shows a quite strong growth in Revenue. The Revenue has grown by 12.24% in the last year.
- TELA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 35.01% yearly.
EPS 1Y (TTM)47.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.76%
Revenue 1Y (TTM)12.24%
Revenue growth 3Y32.99%
Revenue growth 5Y35.01%
Sales Q2Q%9.14%
3.2 Future
- The Earnings Per Share is expected to grow by 18.21% on average over the next years. This is quite good.
- The Revenue is expected to grow by 14.05% on average over the next years. This is quite good.
EPS Next Y38.59%
EPS Next 2Y25.29%
EPS Next 3Y19.66%
EPS Next 5Y18.21%
Revenue Next Year7.66%
Revenue Next 2Y11.37%
Revenue Next 3Y13.04%
Revenue Next 5Y14.05%
3.3 Evolution
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- TELA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year TELA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as TELA's earnings are expected to grow with 19.66% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.29%
EPS Next 3Y19.66%
5. Dividend
5.1 Amount
- No dividends for TELA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TELA BIO INC / TELA FAQ
Can you provide the ChartMill fundamental rating for TELA BIO INC?
ChartMill assigns a fundamental rating of 2 / 10 to TELA.
Can you provide the valuation status for TELA BIO INC?
ChartMill assigns a valuation rating of 0 / 10 to TELA BIO INC (TELA). This can be considered as Overvalued.
Can you provide the profitability details for TELA BIO INC?
TELA BIO INC (TELA) has a profitability rating of 1 / 10.
What is the financial health of TELA BIO INC (TELA) stock?
The financial health rating of TELA BIO INC (TELA) is 3 / 10.
What is the earnings growth outlook for TELA BIO INC?
The Earnings per Share (EPS) of TELA BIO INC (TELA) is expected to grow by 38.59% in the next year.